Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > down,down,down

<< Previous

Bullboard Posts

Next >>

Comment by wizzdumbon Jun 29, 2021 2:38pm

126 Views

Post# 33467136

RE:RE:down,down,down

I don't see that happening. Record third qtr announcement coming up in about six weeks with the following highly likely in the interim:

New QAPs products announced
New distributorships or partnerships with equipment OEMs announced
Large Ontario VTM Purchase Order (which Cameron confirmed will be announced but likely that future ones will not). This will cover fall/winter season so I expect it will be larger than the previous one.